InvestorsHub Logo
Followers 2
Posts 436
Boards Moderated 0
Alias Born 01/14/2014

Re: georgejjl post# 285

Sunday, 01/10/2016 5:06:12 PM

Sunday, January 10, 2016 5:06:12 PM

Post# of 807
Pembrolizumab (formerly MK-3475 and lambrolizumab, trade name Keytruda[1]) is a humanized antibody used in cancer immunotherapy. It targets the programmed cell death 1 (PD-1) receptor.[2] The drug was initially used in treating metastatic melanoma.

HTTPS://www.clinicaltrials.gov/ct2/show/NCT02650999

HTTP://in.reuters.com/article/us-novartis-pricing-idINKBN0U30EV20151220?type=companyNews